The Gray BRCA Pre-Cancer Atlas seeks to transform treatment and prevention for BRCA1/2 mutation-associated cancers through innovative research and new profiling methods.
ADVANCING CANCER RESEARCH
The Gray Foundation is transforming how we identify and study the earliest stages of cancer to enable treatment before the cancer spreads. The Atlas focuses on breast and ovarian cancers and the impact on these diseases of mutations in BRCA1 or BRCA2 genes, which substantially increases the hereditary risk of cancer and also impacts treatment options for spontaneous cancers.
Meet the People Behind the Atlas
Publications & Projects

Multimodal spatial profiling reveals immune suppression and microenvironment remodeling in fallopian tube precursors to high-grade serous ovarian carcinoma.
Explore Data
Publication

Luminal breast epithelial cells of BRCA1 or BRCA2 mutation carriers and noncarriers harbor common breast cancer copy number alterations.
Publication

Brca1 haploinsufficiency promotes early tumor onset and epigenetic alterations in a mouse model of hereditary breast cancer
Publication

H2Bub1 loss is an early contributor to clear cell ovarian cancer progression.
Publication
News
Understanding the earliest stages of ovarian cancer.
News